Health
Study reports lasting immune response in convalescent COVID-19 patients – News-Medical.Net
Researchers report the cellular immune response of convalescent patients in Germany, who recovered from mild or moderate infection compared to that of healthy people…
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus disease 2019 (COVID-19) patients who recovered from mild to moderate disease.
The effect of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies widely among people. Some people show no symptoms, whereas the disease is severe and even fatal in others.
Both humoral immune response, the immune response from antibodies, and cellular…
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Business16 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business18 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.